Skip to content
DataLookout
Menu

NCT07259460

Effects of Dexmedetomidine Target Controlled Infusion on Patient State Index Values and Electroencephalographic Spectrum During Total Intravenous Anesthesia With Propofol

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words
    • Trial completed
    • Final enrollment: 50 participants (planned 60)
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Effects of Dexmedetomidine on Patient State index (PSi) during stable Propofol - Remifentanil general anesthesia
Timeframe: PSi values and DexmedetomidineTarget Controlled Infusion (TCI) concentrations will be monitored during all the time of surgery
Effects of Dexmedetomidine on Electroencephalogram (EEG) power spectrum during stable Propofol - remifentanil general anesthesia
Timeframe: EEG power spectrum and DexmedetomidineTarget Controlled Infusion (TCI) concentrations will be monitored during all the time of surgery
Effects of Dexmedetomidine on Analgesia Nociception Index (ANI) during stable Propofol general anesthesia
Timeframe: ANI values and Sufentanil Target Controlled Infusion (TCI) concentrations will be monitored during all the time of surgery

Secondary (2)

Analgesia Nociception Index (ANI) values and postoperative pain
Patient State Index (PSi) values and postoperative delirium

Sites

1 site in 1 country

  • Treviso Regional HospitalTreviso, TV, Italy